The safety and efficacy of anti-thrombotic agents during mechanical thrombectomy procedure for acute ischemic stroke: A systematic review and meta-analysis

Administration of anti-thrombotic agents during MT may reduce 3- to 6-month mortality without increasing sICH risk. However, they do not appear to significantly improve recanalization rates or functional independence. Given the high heterogeneity in mortality data, these results should be interpreted with caution.